You have no items in your shopping cart.

Product was successfully added to your shopping cart.



Finalist - Financial Review
50 Most Innovative Companies 2016.


MyHealthTest's General Manger Nick Cerneaz is interviewed for NAB Health View

2 Mar 2017

"As demand for pathology testing services increases across the globe, one Australian company is shaking up the sector with a new system enabling people to take their own blood samples at home and then monitor their health online." Have a read of our general Manager Nick Cerneaz's interview with NAB Health View HERE


ITL Limited Rebrands to ITL Health Group

28 Feb 2017

MyHealthTest's parent company ITL Limited has rebranded to ITL Health Group. This rebrand is to unify ITL's four divisions, ITL BioMedical, ITL Healthcare, ITL Clinical and MyHealthTest into one global brand. "Holding an IP portfolio of 48 patents and selling into 55 countries, ITL creates and manufactures leading edge medical devices for the clinical, blood banking and laboratory markets and is a growing provider of specialist ancillary products for the blood culture testing market." Read the full article HERE


ITL's Executive Chairman Bill Mobbs Interviewed on Boardroom.Media

20 Feb 2017

On 20th February Bill Mobbs the Executive Chairman of ITL - MyHealthTest's parent company, was interviewed on Boardroom.Media. Have a listen to Bill discussing ITL and MyHealthTest's continual growth and positive half year results here. To view ITL's half year results see the official ASX Announcement here


Diabetes Research at the University of Sydney – Participants Required

25 Jan 2017

The University of Sydney are researching ways to prevent the onset of diabetes. If you are based in Sydney, are overweight and concerned about diabetes you may be eligible to participate. Participants will receive 12 months’ gold standard medical care and weight loss support free of charge. For more information, click here or go to www.metabolictrial.com.


Innovation Connection Grant

5 Dec 2016

MyHealthTest, in partnership with the University of Canberra, have been awarded a $50K Innovation Connection Grant to fund the development of additional test services, expanding our offering beyond diabetes testing. This grant has been awarded by the Australian Government Department of Industry, Innovation and Science; to read more about the grant, click here.

We look forward to having more test services available for you soon!


MyHealthTest On the Radio

14 November 2016

Today, November 14, is World Diabetes Day with the theme of ‘Eyes on Diabetes’ and a focus on testing for the condition. Radio station 2CC interviewed Marianne Gould from MyHealthTest to discuss diabetes testing and the MyHealthTest service. To listen click here.


MyHealthTest is Looking for Volunteers to Participate in a Research Study into Prostate Conditions

10 November 2016

MyHealthTest is conducting a research study into prostate conditions. If you are a man aged over 60 or if you are man aged under 60 with a known prostate condition we would like to invite you to give a blood sample as part of our research study.

The blood collection trial will be conducted on the 9th November 2016 in Western Sydney at the Nepean hospital, Kingswood. For more information click here.


MyHealthTest in HCF Member Magazine

16 August 2016

MyHealthTest have been featured in the HCF Health Agenda member magazine. MyHealthTest was accepted from over 300 applications into the inaugural HCF Catalyst program for healthcare innovation as part of HCF’s vision to improve healthcare outcomes for all Australians.


National Diabetes Week 2016

10 July 2016

It is National Diabetes Week, MyHealthTest is working to help raise awareness of diabetes and to give people a tool that is simple to use to help detect diabetes and pre-diabetes. See our press release here.


HbA1c testing in ED targets undiagnosed diabetes, pre-diabetes

30 June 2016

Many cases of diabetes are not diagnosed until a person is in the emergency department of a hospital.

A recent study at Blacktown Hospital (Sydney) found that of 4580 people that had blood taken at the emergency department in a 6 week period, 1267 had high blood glucose. These people had an HbA1c test done and over 32% were found to have diabetes that they were not previously aware of.

Dr Tien-Ming Hng said “In areas of high diabetes prevalence, HbA1c screening is an effective means of findings cases of diabetes and prediabetes,” Read the full article here.


Diabetes NSW Product of the Month

20 April 2016

The MyHealthTest® HbA1c Diabetes test has been featured in the Diabetes NSW newsletter as the Product of the Month. MyHealthTest are very proud to partner with Diabetes NSW to bring the convenience of this diabetes test to Diabetes NSW members, where it can be purchased from their online store.


Amputation Rate Increased by 25% in Two Years

16 March 2016

An article in the Sydney Morning Herald this week highlighted the increasing incidence of diabetes and diabetes associated complications. According to Diabetes NSW the incidence of diabetes is growing at 7 per cent to 10 per cent a year and has resulted in an increase in amputations of 25 per cent in two years.

Sturt Eastwood, CEO of Diabetes NSW was quoted in the article as saying "The problem is absolutely going to become worse and worse. There is a stigma associated with it, so now people don't talk about it and are not seeking support ... so we are seeing more and more of these complications. In a year, or a year and a half, diabetes type 2 will be the single largest burden on Australia's health system. By the time you turn 50, quite frankly, you should be getting screened annually for diabetes.”

The MyHealthTest HbA1c test helps people living with diabetes track their HbA1c levels (lower HbA1c levels are proved to be associated with reducing the incidence of diabetes associated complications such as amputations) and for people concerned about diabetes to find out if they are developing the condition.

To read the full article click here.


Be a Part of MyHealthTest Development

2 February 2016

MyHealthTest are developing new tests to help people with prostate, thyroid and heart conditions. If you live in the Canberra area and can spare about 30 minutes of your time to give a blood sample on March 1 or March 3, please contact us on 02 6145 2147 or info@myhealthtest.com. More details are on the attached flyer.

If you are unable to be involved this time but would like to register to participate in future trials please contact us on 02 6145 2147 or info@myhealthtest.com.


MyHealthTest HbA1c Test in the NRMA Open Road Magazine

30 November 2015

MyHealthTest are featured in the November / December issue of the NRMA Open Road magazine as part of the Jumpstart program designed to deliver new products and services to NRMA members.

The convenience of the MyHealthTest HbA1c diabetes test will benefit members living with diabetes and those who are concerned about diabetes. To read the article Click Here


MyHealthTest HbA1c Test Now Available through Diabetes NSW

13 November 2015

MyHealthTest are proud to announce that the MyHealthTest HbA1c test is now available on the Diabetes NSW online store.

The HbA1c test provides people living with diabetes with an average of their blood glucose levels over a 2-3 month period.

For a limited time Diabetes NSW, in partnership with MyHealthTest are also offering a limited number of free HbA1c tests to Diabetes NSW members who are renewing their membership.

Working together to raise awareness of the convenience of the MyHealthTest HbA1c test, Diabetes NSW and MyHealthTest are helping people living with diabetes to better manage their health.


MyHealthTest Diabetes Test at ADS ADEA Annual Scientific Meeting

25 August 2015

Research work on the MyHealthTest HbA1c test by the ANU was presented in a poster at the ADS ADEA ASM in Adelaide in Aug 2015. The poster demonstrated that dried blood spot(DBS) samples gave equivalent results to traditional blood samples, and that the DBS samples were stable over time. To view the poster click here To read the article click here.


MyHealthTest HbA1c Diabetes Test Study Most Popular Article on BMC Clinical Pathology

1 August 2015

There is a lot of interest in the latest research into MyHealthTest’s HbA1c diabetes test. When it was published on July 8, 2015 the paper outlining the ANU’s research comparing dried blood spots to traditional blood samples quickly became the most viewed article on BMC Clinical Pathology that month. To read the article click here.


MyHealthTest HbA1c Diabetes Test in the Canberra Chronicle

14 July 2015

Canberra resident Louise Bresnahan and Diabetes ACT CEO Gil Cremer spoke to the Canberra Chronicle about the benefits offered to people living with diabetes by the new MyHealthTest HbA1c test.  The test will improve the ease by which people can manage diabetes, or test whether they have the condition.  Collecting a small blood sample at home will not only benefit busy people, but will make testing more accessible for people in remote and rural areas. Read the article here.


Major Investor in MyHealthTest

14 July 2014

ASX listed healthcare company ITL Limited has announced that it is investing in newly launched Australian pathology company MyHealthTest.  Under the investment agreement ITL has the exclusive opportunity to acquire up to 100% of MyHealthTest as specified milestones are met.  Read more.


MyHealthTest HbA1c Diabetes Test Featured on WIN News, Canberra

9 July 2015

The MyHealthTest HbA1c Test was featured on Channel 9 WIN News Canberra tonight, capturing feedback from people with diabetes and Diabetes ACT on how this test will help people more easily manage their diabetes and reduce the onset of complications associated with diabetes.  The test is also used to diagnose diabetes. To view the news piece click here.


MyHealthTest HbA1c Diabetes Test Study Published in BMC Clinical Pathology

8 July 2015

A study conducted by researchers at the Australian National University (ANU) comparing the MyHealthTest dried blood spot (DBS) HbA1c test to traditional whole blood collection was published in the scientific peer reviewed journal BMC Clinical Pathology. The study concluded that the MyHealthTest DBS results were comparable to the current gold-standard results from whole blood samples taken via a needle from the vein.  To read the article click here.